Current Edition

news

CureVac vaccine disappoints in key study amid ‘unprecedented’ spread of variants

Dive Brief: An experimental coronavirus vaccine from drugmaker CureVac was only 47% effective at preventing COVID-19 in a preliminary analysis of results from a large …

Continue Reading →
news

Trial failure dashes Biogen hopes for next Alzheimer’s drug

Dive Brief: An experimental Alzheimer’s disease treatment developed by Biogen didn’t slow patients’ decline when compared to a placebo in a mid-stage study, leading the …

Continue Reading →
news

Gene editing biotech Verve to raise $267M in large IPO

Dive Brief: Verve Therapeutics, a high-profile startup developing a more precise form of gene editing, announced Wednesday it raised nearly $270 million in an initial public …

Continue Reading →
news

Lyophilized products are on the rise: Here’s what you need to know

When Spine BioPharma was looking for support in redeveloping and manufacturing a drug product recently, they found a partner in Emergent BioSolutions. As a contract …

Continue Reading →
news

Regeneron antibody cuts risk of COVID-19 death in UK study

Dive Brief: A major study found that Regeneron’s antibody treatment can reduce the risk of death for certain people hospitalized with COVID-19, the first definitive …

Continue Reading →